PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
85183667 |
LAW OFFICE ASSIGNED |
LAW OFFICE 114 |
MARK SECTION |
OWNER SECTION (no change) |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders,
blood disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and
disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and
disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders;
antipsychotics; antidepressants; pharmaceutical preparations for use in the treatment of anxiety spectrum disorders, atherosclerosis and Alzheimer's; pharmaceutical preparations for use in the
treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease, systemic lupus
erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the treatment of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment of
autoimmune disorders; Veterinary preparations for companion animals in the treatment of weight loss, obesity, urine spraying, chronic pain, gastrointestinal disorders, neurodegenerative disorders,
parasitic infestations, neurological disorders, anxiety, hypertension, dermatitis, cancer, anemia associated with chronic renal failure, fleas, pain associated with orthopedic and soft tissue
surgery, chronic kidney disease, and emesis; preparations for destroying vermin, namely, insecticides for use with livestock and livestock premises; veterinary preparations for the treatment, control
and symptomatic relief of infectious and metabolic diseases of livestock; dietary food supplements for animals; antibacterial pharmaceuticals; production enhancement for livestock, namely, medicated
feed and medicated water additives; medicated feed additives and medicated water additives for animals; diagnostic agents, preparations, and substances to identify pathogens or residues of biological
interest for veterinary use |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
06/07/2011 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATURE |
/reljr44/ |
SIGNATORY'S NAME |
Robert E. Lee, Jr. |
SIGNATORY'S POSITION |
Assistant General Patent Counsel |
DATE SIGNED |
11/04/2011 |
FILING INFORMATION |
SUBMIT DATE |
Fri Nov 04 15:17:13 EDT 2011 |
TEAS STAMP |
USPTO/ESU-XX.XXX.XX.XX-20
111104151713335279-851836
67-48051446427941579732c7
eabe1f6fce7b-DA-12154-201
11104103834311564 |
PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: TRULICITY
SERIAL NUMBER: 85183667
The applicant, Eli Lilly and Company, having an address of
Lilly Corporate Center
Indianapolis, Indiana 46285
United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 06/07/2011.
For International Class 005:
Current identification: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood
disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders,
hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders,
neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics;
antidepressants; pharmaceutical preparations for use in the treatment of anxiety spectrum disorders, atherosclerosis and Alzheimer's; pharmaceutical preparations for use in the treatment of diabetes;
pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease, systemic lupus erythematosus, and ankylosing
spondylitis disease; pharmaceutical preparations for use in the treatment of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment of autoimmune disorders;
Veterinary preparations for companion animals in the treatment of weight loss, obesity, urine spraying, chronic pain, gastrointestinal disorders, neurodegenerative disorders, parasitic infestations,
neurological disorders, anxiety, hypertension, dermatitis, cancer, anemia associated with chronic renal failure, fleas, pain associated with orthopedic and soft tissue surgery, chronic kidney
disease, and emesis; preparations for destroying vermin, namely, insecticides for use with livestock and livestock premises; veterinary preparations for the treatment, control and symptomatic relief
of infectious and metabolic diseases of livestock; dietary food supplements for animals; antibacterial pharmaceuticals; production enhancement for livestock, namely, medicated feed and medicated
water additives; medicated feed additives and medicated water additives for animals; diagnostic agents, preparations, and substances to identify pathogens or residues of biological interest for
veterinary use
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of the goods and/or services
listed in the Notice of Allowance or as subsequently modified for this specific class.
This is the first extension request.
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements may jeopardize the validity of the form or any resulting registration, declares that he/she is properly authorized to execute this form on behalf of the applicant; he/she believes the
applicant to be the owner of the trademark/service mark sought to be registered; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief
are believed to be true.
Signature: /reljr44/ Date Signed: 11/04/2011
Signatory's Name: Robert E. Lee, Jr.
Signatory's Position: Assistant General Patent Counsel
RAM Sale Number: 12154
RAM Accounting Date: 11/07/2011
Serial Number: 85183667
Internet Transmission Date: Fri Nov 04 15:17:13 EDT 2011
TEAS Stamp: USPTO/ESU-XX.XXX.XX.XX-20111104151713335
279-85183667-48051446427941579732c7eabe1
f6fce7b-DA-12154-20111104103834311564